---
title: "PanGIA Biotech Announces Peer-Reviewed Study in Diagnostics Showing 97.8% Sensitivity in Detecting Prostate Cancer Using a Urine-Based Liquid Biopsy with Machine Learning"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/281518201.md"
description: "PanGIA Biotech, Inc. announced a peer-reviewed study published in Diagnostics demonstrating its PanGIA Analysis System's 97.8% sensitivity in detecting prostate cancer using a urine-based liquid biopsy powered by machine learning. The study evaluated 283 participants and showed high specificity for high-grade cancers. This innovative approach aims to reduce unnecessary surgical biopsies and supports earlier clinical decision-making. The findings validate PanGIA's platform for broader applications in cancer detection, emphasizing the use of complex biochemical patterns rather than single biomarkers."
datetime: "2026-04-02T11:32:42.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/281518201.md)
  - [en](https://longbridge.com/en/news/281518201.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/281518201.md)
---

# PanGIA Biotech Announces Peer-Reviewed Study in Diagnostics Showing 97.8% Sensitivity in Detecting Prostate Cancer Using a Urine-Based Liquid Biopsy with Machine Learning

On April 2, 2026, in Delray Beach, Florida, PanGIA Biotech, Inc. unveiled significant findings from a peer-reviewed clinical study titled "Urine-Based Machine Learning Assay Detects Prostate Cancer" published in Diagnostics. The study showcased the clinical efficacy of PanGIA Analysis System (PAS) in detecting prostate cancer with remarkable accuracy. The research underscores the potential of PAS to revolutionize prostate cancer diagnosis and treatment.

### Related Stocks

- [PRTG.US](https://longbridge.com/en/quote/PRTG.US.md)
- [SBIO.US](https://longbridge.com/en/quote/SBIO.US.md)
- [FBT.US](https://longbridge.com/en/quote/FBT.US.md)
- [IBB.US](https://longbridge.com/en/quote/IBB.US.md)
- [XBI.US](https://longbridge.com/en/quote/XBI.US.md)
- [LABU.US](https://longbridge.com/en/quote/LABU.US.md)
- [BIB.US](https://longbridge.com/en/quote/BIB.US.md)
- [BBH.US](https://longbridge.com/en/quote/BBH.US.md)
- [IBBQ.US](https://longbridge.com/en/quote/IBBQ.US.md)
- [PBE.US](https://longbridge.com/en/quote/PBE.US.md)

## Related News & Research

- [Allogene's blood cancer therapy delays cancer relapse in mid-stage study](https://longbridge.com/en/news/282537381.md)
- [Revolution Medicines' experimental cancer pill helps improve survival in late-stage study](https://longbridge.com/en/news/282540793.md)
- [FDA Rejection Sparks Questions On Replimune Drug Approval Path](https://longbridge.com/en/news/282577359.md)
- [IDEAYA eye cancer drug combo meets main goal of mid-to-late-stage trial](https://longbridge.com/en/news/282524512.md)
- [FDA Again Rejects Replimune Skin Cancer Therapy, Says Evidence Falls Short](https://longbridge.com/en/news/282376421.md)